189 related articles for article (PubMed ID: 12942367)
1. Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases.
Kanaan Y; Kpenu E; Utley K; Adams-Campbell L; Dunston GM; Brody LC; Broome C
Hum Genet; 2003 Oct; 113(5):452-60. PubMed ID: 12942367
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer.
Gao Q; Tomlinson G; Das S; Cummings S; Sveen L; Fackenthal J; Schumm P; Olopade OI
Hum Genet; 2000 Aug; 107(2):186-91. PubMed ID: 11030417
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 mutations in African Americans.
Panguluri RC; Brody LC; Modali R; Utley K; Adams-Campbell L; Day AA; Whitfield-Broome C; Dunston GM
Hum Genet; 1999; 105(1-2):28-31. PubMed ID: 10480351
[TBL] [Abstract][Full Text] [Related]
4. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2.
Schubert EL; Lee MK; Mefford HC; Argonza RH; Morrow JE; Hull J; Dann JL; King MC
Am J Hum Genet; 1997 May; 60(5):1031-40. PubMed ID: 9150150
[TBL] [Abstract][Full Text] [Related]
5. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
Saxena S; Chakraborty A; Kaushal M; Kotwal S; Bhatanager D; Mohil RS; Chintamani C; Aggarwal AK; Sharma VK; Sharma PC; Lenoir G; Goldgar DE; Szabo CI
BMC Med Genet; 2006 Oct; 7():75. PubMed ID: 17018160
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
7. Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.
Machackova E; Foretova L; Lukesova M; Vasickova P; Navratilova M; Coene I; Pavlu H; Kosinova V; Kuklova J; Claes K
BMC Cancer; 2008 May; 8():140. PubMed ID: 18489799
[TBL] [Abstract][Full Text] [Related]
8. BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer.
Hadjisavvas A; Charalambous E; Adamou A; Christodoulou CG; Kyriacou K
Hum Mutat; 2003 Feb; 21(2):171. PubMed ID: 12552570
[TBL] [Abstract][Full Text] [Related]
9. Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families.
Valarmathi MT; Sawhney M; Deo SSV; Shukla NK; Das SN
Hum Mutat; 2004 Feb; 23(2):205. PubMed ID: 14722926
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
Rashid MU; Zaidi A; Torres D; Sultan F; Benner A; Naqvi B; Shakoori AR; Seidel-Renkert A; Farooq H; Narod S; Amin A; Hamann U
Int J Cancer; 2006 Dec; 119(12):2832-9. PubMed ID: 16998791
[TBL] [Abstract][Full Text] [Related]
11. Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.
de la Hoya M; Osorio A; Godino J; Sulleiro S; Tosar A; Perez-Segura P; Fernandez C; Rodríguez R; Díaz-Rubio E; Benítez J; Devilee P; Caldés T
Int J Cancer; 2002 Feb; 97(4):466-71. PubMed ID: 11802208
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.
Tazzite A; Jouhadi H; Nadifi S; Aretini P; Falaschi E; Collavoli A; Benider A; Caligo MA
Gynecol Oncol; 2012 Jun; 125(3):687-92. PubMed ID: 22425665
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
[TBL] [Abstract][Full Text] [Related]
14. Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14.
Coppa A; Buffone A; Capalbo C; Nicolussi A; D'Inzeo S; Belardinilli F; Colicchia V; Petroni M; Granato T; Midulla C; Zani M; Ferraro S; Screpanti I; Gulino A; Giannini G
Breast Cancer Res Treat; 2014 Dec; 148(3):629-35. PubMed ID: 25395318
[TBL] [Abstract][Full Text] [Related]
15. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
Nanda R; Schumm LP; Cummings S; Fackenthal JD; Sveen L; Ademuyiwa F; Cobleigh M; Esserman L; Lindor NM; Neuhausen SL; Olopade OI
JAMA; 2005 Oct; 294(15):1925-33. PubMed ID: 16234499
[TBL] [Abstract][Full Text] [Related]
16. Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
Ricks-Santi L; McDonald JT; Gold B; Dean M; Thompson N; Abbas M; Wilson B; Kanaan Y; Naab TJ; Dunston G
Ethn Dis; 2017; 27(2):169-178. PubMed ID: 28439188
[TBL] [Abstract][Full Text] [Related]
17. Identification of a founder BRCA2 mutation in Sardinian breast cancer families.
Monne M; Piras G; Fancello P; Santona MC; Uras A; Landriscina G; Mastio G; Gabbas A
Fam Cancer; 2007; 6(1):73-9. PubMed ID: 17216544
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan.
Abu-Helalah M; Azab B; Mubaidin R; Ali D; Jafar H; Alshraideh H; Drou N; Awidi A
Sci Rep; 2020 Oct; 10(1):17573. PubMed ID: 33067490
[TBL] [Abstract][Full Text] [Related]
19. PALB2 analysis in BRCA2-like families.
Adank MA; van Mil SE; Gille JJ; Waisfisz Q; Meijers-Heijboer H
Breast Cancer Res Treat; 2011 Jun; 127(2):357-62. PubMed ID: 20582465
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.
Meindl A;
Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
